October 1, 2020

The Niche

Knoepfler lab stem cell blog

CIRM iPS cells

3 min read

Stem cell technology is poised to wow the world with biomedical advances in the coming decades. Japan wants to lead the way, particularly with applications that focus on a relatively new kind of stem cells called induced pluripotent stem cells or iPS cells. Japanese researcher, Shinya Yamanaka, first reported production of iPS cells in 2006 in mice and in 2007 in humans. Japan has raced ahead of other countries and they appear to have the intellectual property rights and drive to do so. And …Read More